UROV
Urovant Sciences Ltd
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Market Cap: 509 Million
Primary Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET)
Shares Outstanding: 31.7 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.7787565831691772
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Ethical Flags
Longest drawdown: 209 trading days
From: 2020-01-06 To: 2020-11-12
Lowest Point:
Urovant Sciences EPS misses by $0.01
via: SeekingAlpha at 2019-06-13 12:08:44:000
Urovant Sciences (NASDAQ: UROV ): Q4 GAAP EPS of -$0.96 misses by $0.01 . More news on: Urovant Sciences Ltd., Earnings news and commentary, Healthcare stocks news, Read more … read more...
Urovant Sciences Reports Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019
via: Business Wire at 2019-06-13 12:05:00:000
Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today reported financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2019. Recent Business… read more...
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2019 Update
via: SeekingAlpha at 2019-06-12 01:06:09:000
This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsens 13F stock portfolio on a quarterly basis. It is based on Viking Globals regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Ole Andreas Halvorsen… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|